“N-Substituted Thiophenylacetamides Identified as Selective SIRT2 Inhibitors with Anticancer Potential via In Silico Approach”

https://pubmed.ncbi.nlm.nih.gov/38112299

A series of N-(5-phenoxythiophen-2-yl)-2-(arylthio)acetamide derivatives, optimized through an in silico approach, show promise as selective SIRT2 inhibitors, with potential as anticancer drugs.